Caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors

Human Pathology

Volumn 40, Issue 7, 2009, Pages 1050-1052

  Tomita, Tatsuo ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3;

APOPTOSIS; CELL TYPE; DISEASE ASSOCIATION; ENDOCRINE TUMOR; ENZYME ACTIVATION; GASTRINOMA; GLUCAGONOMA; HUMAN; IMMUNOCYTOCHEMISTRY; INSULINOMA; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET CELL TUMOR; PANCREATIC POLYPEPTIDOMA; SOMATOSTATINOMA; TUMOR CLASSIFICATION;

CASPASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; PANCREATIC NEOPLASMS;

EID: 67349141256     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.02.010     Document Type: Letter

References (5)

1. Cohen G.M. Caspases: the excursions of apoptosis. Biochem J 326 (1997) 1-16
2. Hirata H., Takahashi A., Kobayashi S., et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 187 (1998) 587-600
3. Butler A.E., Jansen J., Bonner-Weir S., et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
4. Kloppel G., Perren A., and Heitz P.U. The gastroenteropancreatic neuroendocrine cell system and its tumors. The WHO classification. Ann NY Acad Sci 1014 (2004) 13-27
5. Hruban R.H., Pitna M.B., and Klimstra D.S. Tumors of the pancreas. AFIP atlas of tumor pathology, 4 (2007), AFIP, Washington, DC 251-304